BioSpace News Archive

Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022

Triumvira Immunologics today announced that Senior Management will participate in four upcoming healthcare investor conferences.

October 12, 2022
·
1 min read
Genetown

Apnimed to Participate in the 2nd Annual Needham Biotech Private Company Virtual 1x1 Forum

Apnimed today announced that company management will participate in the 2nd Annual Needham Biotech Private Company Virtual 1x1 Forum taking place October 18-19, 2022.

October 12, 2022
·
3 min read
Genetown

Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase

Palleon Pharmaceuticals today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022.

October 12, 2022
·
1 min read
Genetown

Cyteir Therapeutics Presents Poster on the Identification of Mechanism of Action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium

Cyteir Therapeutics, Inc. today announced that the company will be presenting a poster on the mechanism of action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium at the poster session “Molecular Targeted Agents 1" on Wednesday, October 26, 2022 (Abstract No. 71).

October 12, 2022
·
4 min read
Biotech Bay

Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients With Previously-Treated Spinal Muscular Atrophy (SMA)

Genentech, a member of the Roche Group, announced new two-year data from the JEWELFISH study evaluating Evrysdi® in people with Type 1, 2 or 3 SMA aged 6 months to 60 years at time of enrollment.

October 12, 2022
·
10 min read
Drug Development

Poxel to Present DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022

POXEL SA announced that its late-breaking abstract describing the results from its Phase 2 study of PXL065 in NASH has been selected for an oral presentation at The Liver Meeting® 2022, hosted by the American Association for the Study of Liver Diseases, being held on November 4-8, 2022 in Washington, D.C.

October 12, 2022
·
6 min read
Cellusion and Minaris Regenerative Medicine, a member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy

Cellusion Inc. and Minaris Regenerative Medicine, LLC announced Letter of Intent of the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative therapy in the United States.

October 12, 2022
·
4 min read
Drug Development

Astellas to Present Findings from Phase 3 Long-Term Safety Study of Fezolinetant in Oral Session at The North American Menopause Society 2022 Annual Meeting

Astellas Pharma Inc. will present 52-week results from the Phase 3 SKYLIGHT 4™ clinical study evaluating the safety and tolerability of fezolinetant, an investigational oral, nonhormonal compound being studied for the treatment of moderate to severe vasomotor symptoms associated with menopause.

October 12, 2022
·
9 min read
Business

Philips provides update on its financial performance in Q3 2022

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, provided an update on its third-quarter 2022 financial results and full-year outlook.

October 12, 2022
·
4 min read
Policy

Approval of delisting of Vifor Pharma AG’s registered shares

Vifor Pharma AG announced that Vifor has received approval for the delisting of the totality of Vifor’s registered shares.

October 12, 2022
·
3 min read